Low dose methods for treating disorders in which TNFα activity is detrimental
US8846046B2 · kind B2 · utility
15Cited by
45References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2003 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | Oct 24, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating TNFα disorders is described, wherein the method comprises administering a low dose amount of a TNFα inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.